The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Poseida Therapeutics Inc shares valued at $283,866 were sold by Gergen Mark J on Dec 10 ’24. At $9.46 per share, Gergen Mark J sold 30,000 shares. The insider’s holdings dropped to 651,291 shares worth approximately $6.15 million following the completion of this transaction.
Also, Gergen Mark J sold 30,000 shares, netting a total of over 278,100 in proceeds. Following the sale of shares at $9.27 each, the insider now holds 651,291 shares.
Before that, MARK GERGEN had added 120,000 shares to its account. In a trade valued at $343,200, the Director bought Poseida Therapeutics Inc shares for $2.86 each.
As published in a research note from Piper Sandler on December 02, 2024, Poseida Therapeutics Inc [PSTX] has been rated down from an Overweight to a Neutral and the price target has been revised to $10. Analysts at H.C. Wainwright started covering the stock with ‘”a Buy”‘ outlook in a report released in early January. As of January 07, 2022, Cantor Fitzgerald has initiated its “an Overweight” rating for PSTX. Earlier on May 18, 2021, BTIG Research initiated its rating. Their recommendation was “a Buy” for PSTX stock.
Analyzing PSTX Stock Performance
During the last five days, there has been a drop of approximately -0.74%. Over the course of the year, Poseida Therapeutics Inc shares have jumped approximately 180.95%. Shares of the company reached a 52-week high of $9.58 on 12/12/24 and a 52-week low of $1.87 on 04/16/24. A 50-day SMA is recorded $4.85, while a 200-day SMA reached $3.42. Nevertheless, trading volume fell to 1.23 million shares from 0.74 million shares the previous day.
Support And Resistance Levels for Poseida Therapeutics Inc (PSTX)
According to the 24-hour chart, there is a support level at 9.38, which, if violated, would cause prices to drop to 9.31. In the upper region, resistance lies at 9.53. The next price resistance is at 9.61. RSI (Relative Strength Index) is 86.76 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.06, which suggests the price will decrease in the coming days. Percent R is at 46.67%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.